FDA Inspection 729481 — SPI Pharma, Inc.

SPI Pharma, Inc. — FEI 1833292

The FDA completed an inspection of SPI Pharma, Inc. on May 4, 2011 in Grand Haven, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 4, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Haven, MI (United States)